SP1 and prostate carcinoma: Deng et al. [25] revealed that PRMT5 interacts with BRG1 and Sp1 to induce symmetrical dimethylation modification of H4R3 in the promoter region of the androgen receptor gene, activating androgen receptors and promoting the proliferation of prostate cancer cells.